Comparison of clinical outcomes of conbercept versus ranibizumab treatment for retinopathy of prematurity: a multicentral prospective randomised controlled trial

PURPOSE: To compare the recurrence rate and surgical complications of retinopathy of prematurity (ROP) between patients treated with intravitreal injection of conbercept (IVC) and intravitreal injection of ranibizumab (IVR) within 6 months. METHODS: A multicentral prospective, randomised controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhenquan, Zhao, Jinfeng, Lam, Waiching, Yang, Mingmin, Chen, Lu, Huang, Xuelin, Wei, Meirong, Yang, Hui, Lv, Fan, Zhang, Fuyan, Zeng, Jian, Zhang, Guo-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234416/
https://www.ncbi.nlm.nih.gov/pubmed/33637618
http://dx.doi.org/10.1136/bjophthalmol-2020-318026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234416/
https://www.ncbi.nlm.nih.gov/pubmed/33637618
http://dx.doi.org/10.1136/bjophthalmol-2020-318026

Ejemplares similares